We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-11.83%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.13B
AUM Growth
-$175M
Cap. Flow
+$135M
Cap. Flow %
6.37%
Top 10 Hldgs %
29.49%
Holding
393
New
18
Increased
166
Reduced
132
Closed
19

Top Buys

Rank Stock Value
1
DFUV icon
Dimensional US Marketwide Value ETF
DFUV
+$34.5M
2
BND icon
Vanguard Total Bond Market
BND
+$24.6M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$19.6M
4
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$18.6M
5
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$13.6M

Top Sells

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$44.4M
2
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$5.22M
3
VBK icon
Vanguard Morningstar Small-Cap Growth ETF
VBK
+$5.21M
4
BNDX icon
Vanguard Total International Bond ETF
BNDX
+$1.26M
5
RS icon
Reliance Steel & Aluminium
RS
+$1.05M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.96%
2 Technology 11.56%
3 Healthcare 9.67%
4 Financials 6.9%
5 Consumer Staples 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IJK icon
351
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$209K 0.01%
3,276
– –
IHI icon
352
iShares US Medical Devices ETF
IHI
$3.41B
$207K 0.01%
4,098
-24
-0.6% -$1.31K
MO icon
353
Altria Group
MO
$115B
$206K 0.01%
4,921
+56
+1% +$2.9K
ULTA icon
354
Ulta Beauty
ULTA
$22.2B
$206K 0.01%
+534
New +$212K
FAST icon
355
Fastenal
FAST
$57.1B
$203K 0.01%
8,132
+150
+2% +$4.04K
KMI icon
356
Kinder Morgan
KMI
$70.3B
$198K 0.01%
11,821
-616
-5% -$11.5K
GOF icon
357
Guggenheim Strategic Opportunities Fund
GOF
$2.15B
$167K 0.01%
10,365
+300
+3% +$5.31K
ONCT
358
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$167K 0.01%
7,523
– –
RNAM
359
DELISTED
Avidity Biosciences
RNAM
$164K 0.01%
11,281
– –
IEZ icon
360
iShares US Oil Equipment & Services ETF
IEZ
$386M
$160K 0.01%
10,000
– –
SLQT icon
361
SelectQuote
SLQT
$91.8M
$136K 0.01%
55,000
-25,000
-31% -$64.1K
VTRS icon
362
Viatris
VTRS
$18.8B
$135K 0.01%
12,888
-891
-6% -$9.77K
CMRX
363
DELISTED
Chimerix, Inc.
CMRX
$133K 0.01%
64,055
+10,000
+18% +$32.1K
GRFS
364
Grifois
GRFS
$5.23B
$130K 0.01%
10,955
– –
GOSS icon
365
Gossamer Bio
GOSS
$83.2M
$126K 0.01%
15,100
– –
SNCE
366
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$125K 0.01%
+3,113
New +$227K
TCON
367
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$95K ﹤0.01%
2,373
– –
SIRI icon
368
SiriusXM
SIRI
$9.62B
$63K ﹤0.01%
1,030
– –
GERN icon
369
Geron
GERN
$970M
$61K ﹤0.01%
39,047
– –
LCTX icon
370
Lineage Cell Therapeutics
LCTX
$281M
$51K ﹤0.01%
+32,263
New +$42.5K
SRTA
371
Strata Critical Medical Inc
SRTA
$528M
$45K ﹤0.01%
10,000
– –
VTAK icon
372
Catheter Precision
VTAK
$724K
$21K ﹤0.01%
7
– –
FBIO icon
373
Fortress Biotech
FBIO
$92.4M
$17K ﹤0.01%
1,333
– –
STAB
374
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$8K ﹤0.01%
28,875
– –
AVEM icon
375
Avantis Emerging Markets Equity ETF
AVEM
$28B
– –
-3,472
Closed -$206K
12 13 14
15
16

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q2 2022 Portfolio in Review

As of Q2 2022, Dowling & Yahnke held 393 positions worth $2.13B, down 7.6% from $2.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Dowling & Yahnke deployed $135M of net new capital in Q2 2022, opening 18 new positions and adding to 166 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 1,035,379 shares worth $32.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 45% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $44.4M trimmed.

  • Dowling & Yahnke's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 1,035,379 shares worth $32.7M.
  • Dowling & Yahnke added most to Vanguard Total Bond Market in Q2 2022, an estimated $24.6M increase.
  • Dowling & Yahnke's biggest Q2 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $44.4M.
  • Dowling & Yahnke fully exited Vanguard Russell 2000 ETF in Q2 2022, selling an estimated $696K.
  • Dowling & Yahnke's ten largest holdings make up 29% of its $2.13B portfolio in Q2 2022.
  • Dowling & Yahnke opened 18 new positions and closed 19 in Q2 2022.
  • Dowling & Yahnke's portfolio value fell 7.6% quarter-over-quarter to $2.13B.

Based on Dowling & Yahnke's 13F filing for Q2 2022, filed 10 Aug 2022.